Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1446-1451

  Grassi, Guido ^a,b   Quarti Trevano, Fosca ^a   Seravalle, Gino ^b   Dell'Oro, Raffaella ^a   Dubini, Antonella ^b   Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

AROUSAL; ARTICLE; AUDITORY STIMULATION; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORONARY BLOOD VESSEL; FEMALE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; NERVE POTENTIAL; NORADRENALIN BLOOD LEVEL; OBESITY; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN NERVE; SYMPATHETIC NERVE; SYMPATHETIC TONE; VENOUS BLOOD;

ACOUSTIC STIMULATION; ADULT; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS INDEX; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE, SKELETAL; NOREPINEPHRINE; OBESITY; SKIN; SYMPATHETIC NERVOUS SYSTEM; WAIST-HIP RATIO;

EID: 70149098940     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.028     Document Type: Article

References (27)

1. Lee Z.S., Critchley J.A., Tomlinson B., et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 50 (2001) 135-143
2. Huggett R.J., Burns J., Mackintosh A.F., and Mary D.A. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44 (2004) 847-852
3. Grassi G., Dell'Oro R., Quarti-Trevano F., et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48 (2005) 1359-1365
4. Grassi G., Seravalle G., Quarti-Trevano F., et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49 (2007) 535-541
5. Brunner E.J., Hemingway H., Walker B.R., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
6. Straznicky N.E., Lambert E.A., Lambert G.W., et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 5998-6005
7. Mancia G., Bousquet P., Elghozi J.L., et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 25 (2007) 909-920
8. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 29 (2006) 839-847
9. Maison P., Byrne C.D., Hales C.N., and Wareham N.J. Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous system and the metabolic syndrome?. Metabolism 49 (2000) 81-87
10. Grundy S.M., Cleeman J.I., Daniels S.R., et al., American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
11. Grassi G., Colombo M., Seravalle G., et al. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31 (1998) 64-67
12. Parati G., Casadei R., Groppelli A., Di Rienzo M., and Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 13 6 Pt 1 (1989) 647-655
13. Grassi G., Turri C., Vailati S., Dell'Oro R., and Mancia G. Muscle and skin sympathetic nerve traffic during the "white-coat" effect. Circulation 100 (1999) 222-225
14. Vallbo A.B., Hagbarth K.E., Torebjörk H.E., and Wallin B.G. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59 (1979) 919-957
15. Hagbarth K.E., Hallin R.G., Hongell A., et al. General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 84 (1972) 164-176
16. Delius W., Hagbarth K.E., Hongell A., and Wallin B.G. Manoeuvres affecting sympathetic outflow in human skin nerves. Acta Physiol Scand 84 (1972) 177-186
17. Hjemdahl P., Daleskong M., and Kanan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 25 (1979) 131-138
18. Valensi P., Smagghue O., Pariès J., et al. Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: influence of rheological disorders. Metabolism 49 (2000) 600-606
19. Berne C., Fagius J., Pollare T., and Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35 (1992) 873-879
20. Grassi G. Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens Rep 6 (2004) 236-240
21. Scherrer U., and Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96 (1997) 4104-4113
22. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19 3 Pt 2 (2001) 523-528
23. Mancia G., and Mark A.L. Arterial baroreflexes in humans. In: Shepherd J.T., and Abboud F.M. (Eds). Handbook of physiology, section 2: the cardiovascular system (1983), American Physiological Society, Bethesda (Md) 755-793
24. Grassi G., Bolla G., Seravalle G., et al. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci (Lond) 92 (1997) 285-289
25. Folkow B., Di Bona G.F., Hjemdahl P., et al. Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension 5 (1983) 399-403
26. Grassi G., and Esler M. How to assess sympathetic activity in humans. J Hypertens 17 (1999) 719-734
27. Esler M., Jennings G., Lambert G., et al. Overflow of catecholamine neurotransmitters to the circulation: source, fat and function. Physiol Rev 70 (1990) 963-985